View Financial HealthNu-Med Plus 配当と自社株買い配当金 基準チェック /06Nu-Med Plus配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jul 11Nu-Med Plus, Inc. Announces Management Changes, Effective July 7, 2026On July 7, 2026, Jeffrey L. Robins, a member of the Board of Directors of the Nu-Med Plus, Inc., provided notice to the Board of Directors of the Company of his resignation as a member of the Board of Directors, effective for all purposes as of July 7, 2026. Mr. Robins’ resignation was not a result of any disagreement with the Company on any matter. Effective July 7, 2026, immediately upon effectiveness of Mr. Robins’ resignation, the Board of Directors appointed Mr. Fred Tejada, an Avid Gold Shareholder (the “Appointee” and the “Appointment”), as a member of the Board of Directors (“Board”), to fill the vacancy left by Mr. Robins resignation. Mr. Tejada will serve as a member of the Board of Directors, until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Mr. Tejada was also appointed as the Sr. Vice President and Chief Geologist of the Company by the Board, on July 7, 2026, and effective upon his appointment as a director of the Company. Mr. Tejada brings over 40 years of experience in the exploration and mining industry to the Company. Mr. Tejada previously served as a member of the Board of Directors of Canadian Goldfields Discovery Corp. and as its Chief Executive Officer from July 2017 to December 2025 (TSXV:CGM). From June 2021 to December 2025, Mr. Tejada served as Interim Chief Executive Officer of MegumaGold Corp., having served as Director from June 2016. From February 2021 to September 2024, Mr. Tejada served as Director, Chief Executive Officer (February 2021 to April 2022) and Executive Vice President of Exploration (April 2022 to September 2024), for Kalo Gold Corp. From March 2021 to July 2022, Mr. Tejada served as Director and Technical Lead Advisor for Solis Minerals. From June 2021 to July 2022, Mr. Tejada served as Chief Executive Officer to Volatus Corp. Mr. Tejada graduated with a Bachelor of Science degree in Geology from Adamson University in Manila, the Philippines.お知らせ • Apr 01Nu-Med Plus, Inc. announced delayed annual 10-K filingOn 03/31/2026, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15Nu-Med Plus, Inc. announced delayed 10-Q filingOn 08/14/2024, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15Nu-Med Plus, Inc. announced delayed 10-Q filingOn 11/14/2022, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Oct 23Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of DirectorOn October 18, 2022, the board of directors of Nu-Med Plus, Inc. recognized the need for an additional member of the board of directors, and unanimously consented to appoint Jeffrey L. Robins to the board of director.お知らせ • Sep 14Nu-Med Plus, Inc. Announces Board ChangesOn September 12, 2022, Jeffrey L. Robins resigned as President and Chairman of the Board and Dr. Brett J. Earl resigned as a director. The Corporation has appointed Mr. William Hayde as the President, Director and Chairman of the Board.お知らせ • Aug 14Nu-Med Plus, Inc. announced delayed 10-Q filingOn 08/13/2020, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: NUMDの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: NUMDの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Nu-Med Plus 配当利回り対市場NUMD 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (NUMD)n/a市場下位25% (US)1.3%市場トップ25% (US)4.0%業界平均 (Medical Equipment)1.8%アナリスト予想 (NUMD) (最長3年)n/a注目すべき配当: NUMDは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: NUMDは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: NUMDの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: NUMDが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 15:38終値2026/08/21 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nu-Med Plus, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 11Nu-Med Plus, Inc. Announces Management Changes, Effective July 7, 2026On July 7, 2026, Jeffrey L. Robins, a member of the Board of Directors of the Nu-Med Plus, Inc., provided notice to the Board of Directors of the Company of his resignation as a member of the Board of Directors, effective for all purposes as of July 7, 2026. Mr. Robins’ resignation was not a result of any disagreement with the Company on any matter. Effective July 7, 2026, immediately upon effectiveness of Mr. Robins’ resignation, the Board of Directors appointed Mr. Fred Tejada, an Avid Gold Shareholder (the “Appointee” and the “Appointment”), as a member of the Board of Directors (“Board”), to fill the vacancy left by Mr. Robins resignation. Mr. Tejada will serve as a member of the Board of Directors, until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Mr. Tejada was also appointed as the Sr. Vice President and Chief Geologist of the Company by the Board, on July 7, 2026, and effective upon his appointment as a director of the Company. Mr. Tejada brings over 40 years of experience in the exploration and mining industry to the Company. Mr. Tejada previously served as a member of the Board of Directors of Canadian Goldfields Discovery Corp. and as its Chief Executive Officer from July 2017 to December 2025 (TSXV:CGM). From June 2021 to December 2025, Mr. Tejada served as Interim Chief Executive Officer of MegumaGold Corp., having served as Director from June 2016. From February 2021 to September 2024, Mr. Tejada served as Director, Chief Executive Officer (February 2021 to April 2022) and Executive Vice President of Exploration (April 2022 to September 2024), for Kalo Gold Corp. From March 2021 to July 2022, Mr. Tejada served as Director and Technical Lead Advisor for Solis Minerals. From June 2021 to July 2022, Mr. Tejada served as Chief Executive Officer to Volatus Corp. Mr. Tejada graduated with a Bachelor of Science degree in Geology from Adamson University in Manila, the Philippines.
お知らせ • Apr 01Nu-Med Plus, Inc. announced delayed annual 10-K filingOn 03/31/2026, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15Nu-Med Plus, Inc. announced delayed 10-Q filingOn 08/14/2024, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15Nu-Med Plus, Inc. announced delayed 10-Q filingOn 11/14/2022, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Oct 23Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of DirectorOn October 18, 2022, the board of directors of Nu-Med Plus, Inc. recognized the need for an additional member of the board of directors, and unanimously consented to appoint Jeffrey L. Robins to the board of director.
お知らせ • Sep 14Nu-Med Plus, Inc. Announces Board ChangesOn September 12, 2022, Jeffrey L. Robins resigned as President and Chairman of the Board and Dr. Brett J. Earl resigned as a director. The Corporation has appointed Mr. William Hayde as the President, Director and Chairman of the Board.
お知らせ • Aug 14Nu-Med Plus, Inc. announced delayed 10-Q filingOn 08/13/2020, Nu-Med Plus, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.